Subcutaneous doses of TQ–indirubin-3-monoxime (TQ-I3M) combination suppressed the lung cancer metastasis and reduced tumor growth through the inhibition of Akt/mTOR/NFκB signaling in the xenograft mouse model. Here, AKT1 is linked to neoplasm.